Antitumor Activity of Dehydroxymethylepoxyquinomicin (DHMEQ) in Monotherapy and Combination with Cisplatin in the SKOV-3 Ovarian Cancer Model. Journal of Cancer Research Updates, [S. l.], v. 13, p. 12–18, 2024. DOI: 10.30683/1929-2279.2024.13.03. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/777. Acesso em: 2 may. 2026.